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Mitogen-activated protein kinase (MAPK) pathways
are major signaling systems by which eukaryotic cells
convert environmental cues to intracellular events such
as proliferation and differentiation. We have identified
Giardia lamblia homologues of two members of the
MAPK family ERK1 and ERK2. Functional characteriza-
tion of giardial ERK1 and ERK2 revealed that both ki-
nases were expressed in trophozoites and encysting
cells as 44- and 41-kDa polypeptides, respectively, and
were catalytically active. Analysis of the kinetic param-
eters of the recombinant proteins showed that ERK2 is
5 times more efficient than ERK1 in phosphorylating
myelin basic protein as a substrate, although the phos-
phorylating efficiency of the native ERK1 and ERK2
appeared to be the same. Immunofluorescence analysis
of the subcellular localization of ERK1 and ERK2 in
trophozoites showed ERK1 staining mostly in the me-
dian body and in the outer edges of the adhesive disc
and ERK2 staining in the nuclei and in the caudal fla-
gella. Our study also showed a noticeable change in the
subcellular distribution of ERK2 during encystation,
which became more punctate and mostly cytoplasmic,
but no significant change in the ERK1 localization at
any time during encystation. Interestingly, both ERK1
and ERK2 enzymes exhibited a significantly reduced
kinase activity during encystation reaching a minimum
at 24 h, except for an initial 2.5-fold increase in the
ERK1 activity at 2 h, which resumed back to the normal
levels at 48 h despite no apparent change in the expres-
sion level of either one of these kinases in encysting
cells. A reduced concentration of the phosphorylated
ERK1 and ERK2 was also evident in these cells at 24 h.
Our study suggests a functional distinction between
ERK1 and ERK2 and that these kinases may play a crit-
ical role in trophozoite differentiation into cysts.
Giardia lamblia, an evolutionary primitive eukaryotic pro-
tozoan parasite and an intestinal pathogen of humans and
animals, is one of the major causes of water-borne diseases
worldwide (1). This flagellated protozoan undergoes complex
life cycle stages while inside the host. Exposure to the highly
acidic condition in stomach and proteases in the upper small
intestine triggers excystation of trophozoites from the ingested
cysts. Newly emerged trophozoites swim freely in the intestinal
fluid and colonize the upper small intestine to replicate (2, 3).
As enterocytes migrate to the tip of the villus and get sloughed
off into the intestinal lumen, the attached trophozoites either
reattach to new enterocytes to remain in the intestine or dif-
ferentiate into infective cysts. Although the life cycle of this
primitive eukaryote and physiological signals that regulate
induction of excystation and encystation have been studied
extensively, the molecular mechanisms by which trophozoites
sense and respond quickly to the environmental signals in the
intestine to initiate encystation remain largely unknown.
Encystation is an adaptive process to cope with the depletion
of nutrients, specifically cholesterol, in the presence of high bile
concentration in the lower small intestine (4, 5). It is accom-
plished in three steps as follows: (i) induction of the encysta-
tion-specific gene expression, specifically those that are neces-
sary for the synthesis and processing of cyst wall proteins
(CWP)1 (6–9); (ii) synthesis and intracellular transport of cyst
wall proteins through newly developed secretory organelles
such as Golgi apparatus (10) and encystation-specific vesicles
(11); and (iii) assembly of the extracellular cyst wall (12, 13).
Encysting trophozoites undergo distinct morphological changes
such as disappearance of the median bodies and disorganiza-
tion of the adhesive disc and flagella. The attached trophozoites
gradually round up and detach. They lose mobility and become
refractile as the cyst wall is assembled. The vacuoles that lie
beneath the trophozoite membrane become the periplasmic
space separating the parasite from the cyst wall (14). Unlike
differentiating mammalian cells, giardial differentiation into
cysts initiates in the cells arrested at G2 (15). During encysta-
tion two rounds of DNA replication without an intervening cell
division occur, and nuclear division precedes chromosomal du-
plication (15). The dramatic changes in the cytoskeleton reor-
ganization and gene expression during encystation suggest the
existence of an orchestrated signaling mechanism. We specu-
late that the activation or inactivation of microtubule-associ-
ated proteins and transcription factors by kinases might play
an important role in differentiation of trophozoites into cysts in
response to cholesterol starvation.
A variety of critical cellular functions in eukaryotic cells are
mediated through the MAP kinase pathway in response to
extracellular stimuli (reviewed in Ref. 16). The mammalian
MAP kinases p44 and p42, also known as ERK1 and ERK2, are
serine/threonine kinases and are the two best-studied members
of the MAP kinase family. Full activation of ERK1 and ERK2* This work was supported by the Office of Research and College of
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requires dual phosphorylation at the serine and tyrosine resi-
dues at the TXY motif by MEK1/2 (17, 18). Upon activation,
both ERK1 and ERK2 translocate to the nucleus and phospho-
rylate a variety of proteins including transcription factors, such
as AP-1 (19), Elk1 (20), Ets1 (21), and SREBP (22), that directly
or indirectly stimulate cell proliferation or differentiation.
A differential expression and/or activity of various MAP ki-
nase homologues has been observed in parasitic protozoa. The
fluctuation of expression or activity of MAP kinases has also
been implicated for proliferation, differentiation, or develop-
ment in protozoan parasites. Studies have shown that the
activity of KFR1, a MAP kinase homologue of Trypanosoma
brucei, is higher in the differentiating bloodstream form than
the procyclic form (23). LMAPK, a MAPK homologue of Leish-
mania major, is expressed in promastigotes and amastigotes,
but the activity is detected only in amastigotes. Similarly,
expression of PfMAP2, a MAPK homologue identified in Plas-
modium falciparum, has been detected only in gametocytes of
malaria parasites (24). Here we report functional characteriza-
tion of giardial homologues of ERK1 and ERK2. Our study
provides evidence of differential subcellular localization and
activation of giardial ERK1 and ERK2 in trophozoites and in
encysting cells. Our results indicate, for the first time, that
giardial ERK1 and ERK2 possess functional differences, when
they are thought to have overlapping functions, and that ERK1
and ERK2 may be regulated differentially.
EXPERIMENTAL PROCEDURES
Materials—Unless specified, all materials were obtained from
Sigma, Fisher, and Invitrogen.
Giardia Cell Culture and Differentiation—G. lamblia (WB clone C6,
ATCC 50803) were maintained in TYI-S-33 medium with 10% bovine
serum and bile (25). Encystation was induced essentially as described
by Kane et al. (4). Briefly, encystation was induced by growing tropho-
zoites for one culture cycle in TYI-S-33. Media were poured off along
with unattached trophozoites and replaced with encystation medium
containing 10 mg/ml bovine bile at pH 7.8 and incubated at 37 °C for the
time specified. Encystation medium was replaced with TYI-S-33 me-
dium at 24 h, and incubation was continued for 48 h. Encysting cells
were harvested at different time points by chilling and centrifugation
and subsequently used for protein extraction.
PCR Amplification—A 2.0-kb DNA fragment of ERK1 containing the
entire open reading frame and a 530-bp fragment of ERK2 were ob-
tained by PCR amplification of Giardia genomic DNA using primers
(forward, 5-CCCTAATTAAGCCAGTGACATA-3, and reverse, 5-AA-
GCCCGTAGCCCCAGTTC-3 for ERK1 and forward, 5-GCGGGCAT-
GCTGATTGTGTTAG-3, and reverse, 5-ATAGACGACGATGATAA-
GAG for ERK2) designed using sequences available in the Giardia
Genome Sequencing Data base (27, www.mbl.edu/Giardia/). The ampli-
fied fragments were sequenced, and the ERK2 fragment was used to
screen a Giardia ZapII cDNA library.
Screening of a cDNA Library—The full-length cDNA of the G. lam-
blia homologue of ERK2 was obtained by screening a Giardia ZAPII
cDNA library using a [32P]dATP-labeled ERK2 probe amplified using a
strand-specific primer as described previously (28). Cloned fragments
were sequenced using a capillary electrophoresis-based automated
DNA sequencer (ABI Prism, 310 Genetic analyzer; ABI, Foster City,
CA). Raw output was analyzed using ABI Prism sequence analysis
software. The sequence identity was compared with the NCBI data base
using PSI-BLAST. Multiple sequence alignment was done using
MegAlign program from DNAstar (Madison, WI) software. Molecular
three-dimensional models of gERK1 and gERK2 were generated using
Geno3D on-line model analysis service, and pdb1erk and pdb2erk as
templates, respectively (29).
Southern Blot and Northern Blot—Genomic DNA from Giardia was
isolated using a standard protocol as described by Maniatis and co-
workers (30). Total RNA was extracted using an RNA isolation kit
(Stratagene) according to the supplier’s protocol. 32P-Labeled Giardia
ERK1 (gERK1) and ERK2 (gERK2) cDNA probes were used for South-
ern hybridization as described previously (31). For Northern blots,
strand-specific probes were used (28).
Expression and Purification of Recombinant Protein—The open read-
ing frames of gERK1 and gERK2 were cloned into T7 polymerase-
driven bacterial expression vectors pET41 (Novagen) and pET30Ek/LIC
(Novagen), respectively, according to the manufacturer’s protocol. Two
primers (forward, 5-AGTCCCATGGGAATGCCGCTGGCC-3, and re-
verse, 5-AGTGCGGCCGCTTACATCCACACAGA-3) were designed to
amplify gERK1 ORF (1.158 kb) containing NcoI and NotI sites for
cloning into pET41. The ORF of gERK2 (1.086 kb) was cloned into
pET30 by ligation-independent cloning method (27) using primers
(forward 5-GACGACGACAAGATGTCTGACGACGAAT-3 and reverse
5-GAGGAGAAGCCCGGTTCACTCGTCTTCCTT-3). Expression con-
structs were used to transform BL21(DE3) Escherichia coli cells. Trans-
formed cells were induced with either 1.0 mM isopropyl-1-thio--D-
galactopyranoside (ERK1) or 0.5 mM (ERK2) isopropyl-1-thio--D-
galactopyranoside at 25 °C to overexpress recombinant gERK1 (75 kDa)
and gERK2 (47 kDa) as glutathione S-transferase-tagged and His-
tagged fusion proteins, respectively. Expressed proteins were purified
through cobalt affinity column (TALON superflow resin, Clontech Lab-
oratories) and used for in vitro kinase assays and generation of rabbit
polyclonal antibodies through a commercial vendor (Cocalico, Reams-
town, PA). The His tag (pET30 ERK2) and glutathione S-transferase
tag (pET41 ERK1) sequences added 6 and 31 kDa of molecular masses
to the fusion proteins, respectively.
Western Blot and Immunoprecipitation—Trophozoites or encysting
cells at different time points were harvested, and crude cell extracts (50
g) in Tris-HCl (100 mM, pH 7.0) were used for immunodetection of
endogenous dephosphorylated ERK1 and ERK2 using anti-gERK1 and
anti-gERK2 polyclonal antibodies. Phosphorylated ERK1 and ERK2 in
the crude extracts with or without treatment with  phosphatase (2000
units for 30 min at 30 °C) were detected by an anti-phospho-ERK
polyclonal antibody that recognized both ERK1 and ERK2 (Cell Signal-
ing Technologies). Expression of CWP1 in encysting cells was detected
by immunoblot analysis using anti-CWP1 monoclonal antibody (kindly
provided by Dr. Henry Stibbs, Waterborne Inc.). Positive signals were
detected using a chemiluminescence kit (Pierce) and an anti-rabbit or
anti-mouse horseradish peroxidase-conjugated secondary antibody. For
immunoprecipitation (28), trophozoites or encysting cells were lysed in
TAN buffer (10 mM Tris acetate, pH 8.0, 1% Nonidet P-40, 100 mM
NaCl, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluo-
ride, 1 g/ml leupeptin, and 2 g/ml aprotinin). Crude cell extracts were
treated with rabbit serum followed by protein A-agarose beads to elim-
inate nonspecific binding of proteins to antibody. The protein A-agarose
beads were collected by centrifugation, and the supernatants were
incubated with the appropriate antibody. Protein-antibody complexes
were captured by protein A-agarose beads, washed, and collected by
centrifugation. Protein A-agarose beads bound to the immune complex
were then resuspended in 100 mM Tris, pH 7.0, and used for subsequent
experiments.
Kinase Assay—Purified recombinant gERK1 and gERK2 (5 g) or
semi-compact protein A-agarose beads pellets of immunoprecipitated
gERK1 and gERK2 (25 l) were used in a 50-l reaction containing 100
mM Tris-HCl, pH 7.5, 600 M ATP, 1 mM MgCl2 (ERK2) or 10 mM MgCl2
(ERK1), 6 nM [-32P]ATP, and 100 M of myelin basic protein (MBP).
The reaction mixture was incubated at 30 °C for 10 (ERK2) or 30 min
(ERK1), and 30 l (recombinant protein only) were spotted on phospho-
cellulose filter discs after addition of 5 l of EDTA (100 mM) to stop the
reaction. Filter discs were washed with 1% H3PO4, and bound radioac-
tivity was detected in a liquid scintillation counter (Beckman Instru-
ments). The remaining 20 l of the reaction mix (recombinant protein)
or the 50 l of the reaction mix (immunoprecipitated protein) was
combined with 4 Laemmli sample buffer and resolved in SDS-PAGE
(12–14%). Phosphorylation of MBP was detected by autoradiography
and PhosphorImager (Amersham Biosciences) analysis.
Immunofluorescence Analysis—Trophozoites (350–700 cells/ml) were
cultured on 12-mm glass coverslips placed in 24-well tissue culture
dishes and allowed to grow for 65–70 h in an AnaeroPack jar (Mit-
shubishi Gas Chemical Co.) at 37 °C. In some experiments, trophozoites
were exposed to encystation medium, and cells were fixed after the
specified time. Trophozoites or encysting cells attached on coverslips
were fixed in 100% chilled methanol (20 °C) for 10 min at 20 °C and
further permeabilized with 0.5% Triton X-100 in PBS for 10 min at
room temperature. Permeabilized cells were blocked in blocking buffer
(5% goat serum and 1% glycerol in PBS) and incubated with appropri-
ate rabbit polyclonal antibody (ERK1 1:3000 and ERK2 1:6000 in block-
ing buffer). At the end of incubation, cells were washed with PBS and
incubated with an Alexa 488-conjugated anti-rabbit (Molecular Probes,
Eugene, CA) secondary antibody diluted in blocking buffer (1:100). Cells
were washed in PBS and counterstained with DAPI (0.1 M). Cells were
washed in PBS and post-fixed with 4% paraformaldehyde (Electron
Microscopy Sciences), rinsed with PBS and mounted on Gelmount















(Biomeda Corp.). Localization of the target proteins was detected in a
Delta Vision Image Restoration Microscope using SoftWoRX image
analysis software. DIC images of the localization were captured in a
Zeiss LSM 510 laser scanning confocal microscope.
RESULTS
Sequence Characterization and Expression Analysis of
gERK1 and gERK2—We have cloned giardial homologues of
ERK1 (ORF 1.15 kb, 386 amino acids) by direct PCR amplifi-
cation of the genomic DNA and ERK2 (ORF 1.086 kb, 362
amino acids) by screening a ZAPII Giardia cDNA library.
Upon screening the library using a 530-bp fragment as a probe,
a 1.15-kb cDNA clone of ERK2 was obtained (GenBankTM
accession number AY149274 for ERK1 and accession number
AY149275 for ERK2). Multiple sequence analysis of the trans-
lated amino acid sequence of the ORF showed that Giardia
ERK1 had 51% identity with Dictyostelium discoideum ERK1,
49% identity with Chlamydomonas reinhardtii MAPK, 48%
identity with Arabidopsis thaliana MAPK, 42% identity with
Schizosaccharomyces pombe SPK1, and 43% identity with hu-
man ERK1 with a probability score between e-100 and 1e-76.
The deduced amino acid sequence of Giardia ERK2 ORF ex-
hibited 66% identity with D. discoideum ERK2, 59% identity
with L. mexicana MAPK2, 57% identity with P. falciparum-
MAPK1, and 50% identity with human ERK8 with a probabil-
ity score between e-131 and 2e-94. The gERK2 cDNA clone
contains a short 9-bp 5- and a 56-bp 3-untranslated sequence
that are typical for Giardia transcripts. Multiple sequence
alignment of the amino acid sequence of the ERK1/2 catalytic
domain revealed that all 11 subdomains, characteristic of ser-
ine/threonine kinases, are present in both gERK1 and gERK2
(Figs. 1A and 2A). This includes the consensus motif
GXGXXGXV (Gly26–Val33 gERK1 and Gly25–Val32 gERK2) in
subdomain I for anchoring non-transferable phosphates of
ATP, the invariant Lys (Lys-48 ERK1 and Lys-47ERK2) and the
surrounding region (Val45–Ser51, ERK1, Val44–Ser50 ERK2) in
subdomain II for binding and orienting ATP for maximum
enzymatic activity, and the glutamic acid (Glu66 ERK1, Glu65
ERK2) in the subdomain III involved in formation of a salt
bridge with Lys48 and Lys47. The catalytic loops in both ERK1
and ERK2 are nearly 100% homologous with the HRDLKXXN
motif (His143–Asn150 ERK1 and His138–Asn145 ERK2). The con-
served TXY motif for dual phosphorylation (Thr191–Tyr193
ERK1 and Thr180–Tyr182 ERK2) for the activation of the en-
zyme is also present. Five other amino acids, Phe54 (PheF53
gERK2), Arg62 (Arg61 gERK2), His121 (His116 gERK2), Lys134
(Lys129 gERK2), and Cys157 (Cys152 gERK2), considered to be
FIG. 1. Multiple sequence alignment and structural analysis of gERK1. A, Gl, G. lamblia; Sp, S. pombe; Hs, Homo sapiens; Dd, D.
discoideum. The solid bars above the sequences indicate the G loop, the invariant Lys48 (black arrow) and surrounding region, the catalytic loop,
the TXY motif, and APE site, respectively. Black arrows indicate the conserved Phe54, Arg62, Glu66, His121, Lys134, and Cys157, respectively. The
black double-headed arrows indicate the 10-amino acid insertion. B, three-dimensional model of gERK1. C, three-dimensional model of rat ERK.
White arrows indicate additional -helices.















the signature residues for MAPK as they are not shared by any
other kinases including the CDKs (32), are also present in
gERK1 and gERK2. Molecular three-dimensional modeling of
gERK1 and gERK2 revealed the presence of additional -heli-
ces (Fig. 1, B and C, and Fig. 2, B and C) in giardial ERK1/2
when compared with rat extracellular signal-regulated kinase
(pdb1erk) and phospho-ERK2 (pdb2erk) indicating significant
structural differences between mammalian ERK1/2 and giar-
dial ERK1/2. Functional implication of these additional -hel-
ices is unclear at this moment.
Analysis of genomic organization by Southern blot and
search of Giardia genome sequence data base suggest that both
gERK1 and gERK2 are single copy genes (data not shown).
Northern blot analysis of gERK1 and gERK2 revealed that
both are expressed as a single transcript of 1.3 kb for ERK1 and
1.2 kb for ERK2, respectively, in trophozoites (data not shown).
Analysis of the protein products by Western blotting of cell
extracts indicated that the expression of the 44-kDa gERK1 or
the 41-kDa gERK2 did not fluctuate during growth and encys-
tation (Figs. 8 and 9). The size of the native gERK1 and gERK2
was in agreement with the deduced amino acid sequences from
the ORFs.
Giardial ERK1 and ERK2 Were Catalytically Active—For
functional characterization of gERK1 and gERK2, the catalytic
activity of the recombinant ERK1 and ERK2 was determined
next using MBP as the substrate. In vitro kinase assays re-
vealed that both recombinant ERK1 and ERK2 were catalyti-
cally active (Fig. 3) and phosphorylated MBP with different
efficiency (specific activities: 3.7  0.3 nmol of phosphate/mol
of ERK1/s and 20.1  0.06 nmol of phosphate/mol of ERK2/s).
Recombinant ERK2 was 5 times more efficient than ERK1 in
incorporating phosphates into MBP and was capable of auto-
phosphorylation (Fig. 3, E and C). No autophosphorylation was
noted for gERK1, which suggests that gERK1 possibly can
maintain a basal level of activity without being activated by
phosphorylation (Fig. 3A). This is apparently reflected into the
lower efficiency of phosphorylation of MBP by the recombinant
gERK1, and therefore, the activity of the recombinant gERK1
may not represent the full phosphorylating potential of the
endogenous gERK1. At the standard reaction conditions using
5 g of the enzyme and varying concentrations of MBP, the
apparent Km values for the MBP were in the micromolar range
(31.8  8.5 M ERK1 and 33.1  7.3 M ERK2) (Fig. 3, B, D and
E), which are close to that reported for the mouse ERK2 (33).
Both ERK1 and ERK2 preferred ATP to GTP as the phosphate
donor (ERK1, Mg2ATPKm 265.5  36.0 M; ERK2,
Mg2ATPKm 32.1  2.5 M); however, ERK2 was 8 times more
efficient in utilizing ATP than ERK1. Giardial ERK1 and
FIG. 2. Multiple sequence alignment and structural analysis of gERK2. A, Gl, G. lamblia; Dd, D. discoideum; Hs, H. sapiens; Lm,
L. mexicana. The solid bars above the sequences indicate the G loop, the invariant Lys47 (black arrow) and surrounding region, the catalytic loop,
the TXY motif, and APE site, respectively. Black arrows indicate the conserved Phe53, Arg61, Glu65, His116, Lys129, and Cys152 respectively. The
black diamond shows serine instead of alanine in the APE site. B, three-dimensional model of gERK2. C, three-dimensional model of rat ERK2.
White arrow indicates additional -helix.















ERK2 also favored Mg2 than Mn2 as the divalent cation
(ERK1, MgKm, 1.53  0.4 mM; ERK2, MgKm, 0.265  0.001 M)
(Fig. 3E).
Although the kinetic parameters for the recombinant gERK2
were comparable with that for the mammalian ERK2, the
catalytic efficiency of the recombinant gERK1 was relatively
poor. To determine the catalytic activities of the endogenous
ERK1 and ERK2, we immunoprecipitated ERK1 and ERK2
from the trophozoite extracts using anti-gERK1 and -gERK2
rabbit polyclonal antibodies. The specificity of the anti-ERK1
and -ERK2 antibodies was determined previously by Western
blot analysis of the purified recombinant enzymes and crude
trophozoite extracts (Fig. 4 and 5), which indicated a single
peptide band of 75 kDa for the recombinant ERK1 and a 44-
kDa polypeptide band for the endogenous ERK1 recognized by
the antibody at a dilution of 1:4000 (Fig. 4, A and B). Similarly,
anti-ERK2 antibody recognized a single major polypeptide
band of 47 kDa for the recombinant ERK2 and a 41-kDa band
for the endogenous ERK2 at a dilution of 1:30,000 (Fig. 5, A and
B). Neither ERK1 nor ERK2 antibodies cross-reacted with the
recombinant gERK2 or gERK1, respectively (data not shown).
Immunoprecipitated ERK1 and ERK2 were subjected to in
vitro kinase assays using MBP as the substrate. Results pre-
sented in Figs. 4 (C and D) and 5 (C and D) indicated that both
endogenous ERK1 and ERK2 were catalytically active and
capable of phosphorylating MBP.
Giardial ERK1 and ERK2 Showed Differential Subcellular
Localization—To assess the functional role of giardial ERK1
and ERK2 and whether they have overlapping functions, we
monitored intracellular distribution of ERK1 and ERK2 by
immunofluorescence analysis using primary antisera specific
for gERK1 and gERK2 and deconvolution restoration micros-
copy. Signals obtained for the ERK1 antibody indicated local-
ization of ERK1 mostly in the flagellar basal bodies and in the
median body. Localization of ERK1 was also seen in the adhe-
sive disc, the ventral groove, and along the caudal flagella (Fig.
6A). On the other hand, signals for the ERK2 antibody were
mostly at the cell membrane, at the anterior and caudal fla-
gella, and in the nuclei (Fig. 7A). In support of the studies
indicating that mammalian ERK1 and ERK2 are two microtu-
bule-associated proteins (34), the overall pattern of gERK1 and
gERK2 localization to the specific intracellular structures is
suggestive of their possible association with cytoskeletal
structures.
Altered Localization, Phosphorylation, and Catalytic Activity
of ERK1 and ERK2 during Encystation—Giardia trophozoites
undergo remarkable structural changes during encystation
that are associated with altered intracellular events, such as
disappearance of the median body, cell cycle arrest, appearance
of encystation-specific vesicles, and increased synthesis and
transport of cyst wall proteins. Because ERK1 and ERK2 from
higher eukaryotes are known to be involved in a variety of
cellular functions associated with cell proliferation and cellular
differentiation (35, 36), we set out to analyze intracellular
localization and catalytic activity of ERK1 and ERK2 at differ-
ent stages of encystation by immunofluorescence analysis and
in vitro kinase assays of the immunoprecipitated samples. Tro-
phozoites were treated with the encystment media and har-
FIG. 3. Phosphorylation of MBP by gERK1 and gERK2. A and C, upper panel, Coomassie Blue-stained SDS-PAGE showing increasing
concentration of MBP in the kinase assay of ERK1 and ERK2, respectively. Lower panel, autoradiogram showing phosphorylated MBP and ERK2
(C) and no phosphorylation in the MBP only lane (A). B and D, non-linear plots of the phosphorylated MBP from filter binding kinase assay of ERK1
and ERK2. Each point represents the mean of three separate experiments. D, specific activity and apparent Km for MBP, ATP, and MgCl2 for ERK1
and ERK2.















vested at 2, 6, 10, 24, and 48 h. A distinct change in the
localization of ERK2 in the encysting cells was seen as early as
2 h of encystation, in which the antibody showed a punctate but
even staining throughout the cytoplasm. No staining in the
nuclei or in the flagella by the antibody was noted at 2, 24, and
48 h following exposure to the encystment media (Fig. 7, B–D).
At 24 h, localization of ERK2 was seen mostly toward the
posterior end of the cell and surrounding the large vesicle-like
structures (Fig. 7C), which started to appear around 10 h
during encystation (data not shown). At 48 h, more cells with
vesicles were present, and similar staining of ERK2 was seen
in the cytoplasm and at the perivesicular region. On the other
hand, a more subtle change in the localization of ERK1 was
noted during encystation, which includes lack of staining in the
caudal flagella at 2 h onward and in the median body presum-
ably because of the disappearance of the flagella and the me-
dian body at the early stage of encystation (Fig. 6, B–D). Also,
accumulation of ERK1 in the ventral groove was evident in
encysting cells at 24 h. No alteration in the staining of ERK1 in
the adhesive disc and in the flagellar basal bodies was noted
in any stages of encystation. The observation that ERK1 and
ERK2 are targeted to different locations in trophozoites and
that localization of both proteins changes during encystation
suggests a possible functional difference between gERK1 and
gERK2 and important roles of ERK1 and ERK2 during giardial
differentiation.
To understand the roles played by gERK1 and gERK2 during
encystation, we next monitored the catalytic activity of ERK1
and ERK2 in encysting cells, as it is well known that signals for
both cell proliferation and differentiation are mediated through
activation or inactivation of ERK1 and ERK2 (36, 37). Although
immunoblot analysis indicated no significant change in the
expression of either ERK1 or ERK2 in encysting cells at differ-
ent stages of encystation (Figs. 8A, 9A, and 10C, panel a),
altered activities of both kinases were apparent when phospho-
rylation of MBP by the immunoprecipitated enzymes was used
to monitor the catalytic activity. At 2 h of encystation, a 2.5-
fold increase in the activity of ERK1 was noted which gradually
declined during 6 and 10 h reaching the lowest point at 24 h. At
48 h, the activity of ERK1 resumed back to the level of unin-
duced cells (Fig. 8, B–D). Interestingly, the activity of ERK2
dropped significantly at 2 h and remained at that level until
10 h. At 24 h, the activity of ERK2 in encysting cells reached
the minimum level but recovered back to the uninduced level at
48 h, thus exhibiting a 5–8-fold increase in the activity within
24 h (Fig. 9, B–D). Also, it is noteworthy that the catalytic
activity of both ERK1 and ERK2 in encysting cells was mini-
mum at 24 h when the maximum number of cysts appeared in
the culture medium.
Because the activity of ERK1 and ERK2 depends on the
activating phosphorylation of these two proteins, we set out to
assess the phosphorylation status of ERK1 and ERK2 at dif-
ferent stages of encystation using a phospho-ERK antibody
generated against a 20-amino acids peptide antigen around the
TXY motif of human p44 ERK1, which showed 65 and 52%
identity with the same region of the giardial ERK1 and 2,
respectively. Immunoblot analysis revealed that the concentra-
tion of phospho-ERK1 in encysting cells remained the same as
that of the untreated trophozoites until 10 h except for a mar-
ginal increase at 2 h (Fig. 10C, panel b). A significant decrease
in the phospho-ERK1 concentration was noted in the encysting
cells at 24 h, which was possibly reflected into the decreased
kinase activity at that stage. The concentration of phospho-
ERK2 in encysting cells showed a slight decrease in 6 and 10 h
but a dramatic drop at 24 h confirming the minimum kinase
FIG. 4. Immunoblot analysis and kinase assay of immunopre-
cipitated ERK1. A, Western blot analysis of the recombinant ERK1 (2
g) showing a single 75-kDa band using anti-gERK1 antibody (1:
2500). B, Western blot analysis of the native ERK1 in the crude tro-
phozoite extract (50 g) showing a single polypeptide of 44 kDa at
different dilutions of the antibody (lane 1, 1:500; lane 2, 1:1000; lane 3,
1:2000, lane 4, 1:3000; lane 5, 1:4000; lane 6, preimmune serum). C,
panel 1, Coomassie-stained SDS-PAGE of the kinase assay using im-
munoprecipitated extract showing MBP and ERK1 polypeptides. Panel
2, autoradiogram of the kinase assay showing phosphorylated MBP. D,
Western blot of the immunoprecipitated extract showing the ERK1
polypeptide.
FIG. 5. Immunoblot analysis and kinase assay of immunopre-
cipitated ERK2. A, Western blot analysis of the recombinant ERK2 (2
g) showing a single 47-kDa band using anti-gERK2 antibody (1:
6000). B, Western blot analysis of the native ERK1 in the crude tro-
phozoite extract (50 g) showing a single polypeptide of 41 kDa at
different dilutions of the antibody (lane 1, 1:5,000; lane 2, 1:10,000; lane
3, 1:15,000, lane 4, 1:20,000; lane 5, 1:25000; lane 6, 1:30,000; lane 7,
preimmune serum). C, panel 1, Coomassie-stained SDS-PAGE of the
kinase assay using immunoprecipitated extract showing MBP and
ERK2 polypeptides. Panel 2, autoradiogram of the kinase assay show-
ing phosphorylated MBP. D, Western blot of the immunoprecipitated
extract showing the ERK2 polypeptide.















activity as observed at that stage of encystation. Although at a
much lower intensity, the band corresponding to phospho-
ERK2 was detectable at 48 h representing an increased phos-
phorylation of ERK2, while concentration of the phosphoryl-
ated ERK1 remained low at 48 h. The expression of cyst wall
protein 1 (CWP1) was used as a marker for the encystation
process, which showed an increased expression of CWP1 at 10
and 24 h, as expected (Fig. 10C, panel c). Recognition of the
phospho-gERK1 and -2 by the anti-phospho-ERK antibody was
validated by the treatment of the crude trophozoite extracts
with -phosphatase, which resulted in disappearance of the
polypeptide bands corresponding to the phospho-gERK1 and -2
(Fig. 10A). Furthermore, phospho-ERK antibody did not recog-
nize the recombinant gERK1 and -2 (Fig. 10B).
DISCUSSION
ERK1 and ERK2 are two highly conserved ubiquitously ex-
pressed enzymes in a variety of organisms and play a pivotal
role in regulating complex cellular processes in response to
environmental cues. To understand the functional role of
MAPK in growth and differentiation of Giardia trophozoites,
we characterized giardial homologues of ERK1 and ERK2. Se-
quence analysis indicated that over 50% identity exists be-
tween gERK1/gERK2, and the orthologues from other model
organisms and the Giardia homologues contain all subdomains
that are conserved in other eukaryotes. However, a 10-amino
acid insertion of unknown significance is present in ERK1 at
the activation domain before the TXY motif, which is not
shared by other ERK1 or ERK2 from different species (Figs. 1A
and 2A). Computer-based three-dimensional modeling indi-
cated distinct differences in the structures of giardial ERK1/2
when compared with the mammalian ERK1/2, although the
overall structures were the same (Fig. 1, B and C, and Fig. 2, B
and C). Both recombinant and native ERK1 and ERK2 were
catalytically active and phosphorylated myelin basic protein, a
widely used substrate for ERK1 and ERK2 in assay systems.
Thus, the structural similarity and substrate specificity con-
FIG. 6. Immunofluorescence analy-
sis of gERK1. Immunofluorescence mi-
croscopy was employed to investigate
whether there was any change in the cel-
lular localization of gERK1 during encys-
tation. Trophozoites were seeded onto
coverslips and grown in growth medium
for 24 h before encystation was induced
with encystment medium. At the indi-
cated time points the cells were fixed and
permeabilized. Distribution of gERK1
was detected using anti-gERK1 poly-
clonal antiserum (1:3,000) and anti-rabbit
ALEXA Fluor-488 (green). Nuclei were
stained with DAPI (blue). A, trophozoites,
BB, basal bodies; MB, median body; AD,
adhesive disc. B–D, encysting cells at 2,
24, and 48 h. VG, ventral groove. Inset,
DIC and DIC plus fluorescence merge im-
ages of the localization.
FIG. 7. Immunofluorescence analy-
sis of gERK2. Immunofluorescence mi-
croscopy was used to investigate whether
there was any change in the cellular lo-
calization of gERK2 during encystation.
Trophozoites were seeded onto coverslips
and treated the same way as mentioned
in Fig. 6. Cells at the indicated time
points were fixed and permeabilized. Lo-
calization of gERK2 was detected using
anti-gERK2 polyclonal antiserum
(1:6000) and anti-rabbit ALEXA Fluor-
488 (green). Nuclei were stained with
DAPI (blue). A, trophozoites; AF, anterior
flagella; CF, caudal flagella; N, nucleus.
B, C, and D, encysting cells at 2, 24, and
48 h. V, vesicles. Inset, DIC and DIC plus
fluorescence merge images of the
localization.















firm that the cloned ORFs are of gERK1 and gERK2. In addi-
tion, search of the large scale Giardia genome sequencing data
base (www.mbl.edu/Giardia/) revealed the presence of putative
homologues of giardial MEK and MEKK (data not shown)
suggesting the possibility of the presence of the three-kinase
module of MAPK pathway in Giardia. The presence of ERK1
and ERK2 genes in Giardia, a primitive eukaryote that is
believed to be the earliest diverging member of the eukaryotic
line of descent, raises the enticing possibility that they might
play an important role in giardial growth and differentiation.
Analysis of the kinetic parameters of the recombinant ERK1
and ERK2 indicated that ERK2 was more efficient in phospho-
rylating MBP than ERK1, although the immunoprecipitated
ERK1 phosphorylated MBP with apparently similar efficiency.
It is possible that the full activation of gERK1 requires the
activating phosphorylation at the TXY motif by MEK, which
could be partially achieved by the recombinant ERK2 through
autophosphorylation. Both gERK1 and gERK2 required low
amounts of Mg2 as the divalent cation. MnCl2 and a higher
concentration of MgCl2 completely inhibited phosphorylation
by both kinases (data not shown).
Because ERK1 and ERK2 phosphorylate a variety of pro-
teins, intracellular localization of these kinases defines their
functional specificity. Accordingly, the precise distribution of
ERK1 in the basal bodies, the median body, and in the adhesive
discs may signify a possible interaction of ERK1 with proteins
associated with these structures. Basal bodies of the flagellated
cells are rod-like structures that correspond to the centrosomes
of the higher eukaryotic cells and are associated with origins of
the flagellar axonemes. In flagellated cells, basal bodies are
involved in flagellar motility; therefore, localization of ERK1
into basal bodies presumably reflect its potential association
with microtubule-associated proteins. This assumption is
based on the findings that the association of mammalian ERK1
and ERK2 with the microtubule-binding protein tubulin played
an important role in the spindle assembly checkpoint (38), the
mammalian ERK interacts with the spindle microtubule motor
CENP-E during mitosis (39), and that the active ERK associ-
ates with microtubules and regulates microtubule stability in
fibroblasts and breast epithelial cells (40). It is possible that
gERK1 may associate with tubulins in the median body and
adhesive discs for the maintenance of microtubule stability.
Staining with the gERK2 antibody showed a distinctly differ-
ent pattern of gERK2 localization, in particular to the cell
membrane, anterior and caudal flagella, and presumably to the
nuclei, which suggests a possible interaction of gERK2 with
microtubule-associated proteins in cytoskeletal structures dif-
ferent from what was observed with gERK1. It is well docu-
mented that mammalian ERK1 and -2 translocate to the nu-
cleus upon activation where they phosphorylate specific
transcription factors (16, 41). So far no information is available
on the specific transcription factors in Giardia that are phos-
phorylated by ERK. Detailed studies are required to under-
stand the function of the subset of ERK1 and ERK2 targeted to
various cytoskeletal structures and to the nuclei in Giardia.
Analysis of the distribution of ERK1 and ERK2 in encysting
cells revealed an evident relocation of ERK2 in the cytoplasm.
Redistribution of ERK2 was noticeable as early as 2 h of en-
cystation, which did not change significantly in the latter part
of encystation, except for its localization around the perivesicu-
lar region of the large vesicle-like structures that were present
in the encysting cells at 24 and 48 h. On the other hand,
localization of ERK1 did not alter significantly except for the
high intensity staining by the antibody in the ventral groove
area at 24 h. The ventral groove is a shallow region, which
extends from the adhesive disc to the caudal region of the body
and is the site of origin of the ventral flagellar pair. It is
believed that the ventral groove generates the force to develop
a negative pressure inside the adhesive disc for the attachment
of the parasite (14, 42). The rationale for the accumulation of a
subset of ERK1 in this area is unclear. The disappearance of
ERK1 staining in the median body at 24 and 48 h was due to
disorganization of the median body during encystation. Inter-
estingly, a parallel fluctuation in the kinase activity of the
endogenous ERK2 and ERK1 was noted during encystation. A
significantly reduced activity of ERK2 was maintained up to
24 h as long as the cells were exposed to the encystation
medium. Interestingly, upon replacement of the encystation
medium with the regular growth medium, a 5–8-fold increase
in the activity was noted within 24 h. The activity of ERK1
instead was biphasic with an initial 2.5-fold increase followed
by a gradual decline until 24 h. Upon replacement of the
regular medium at 24 h, the activity was restored to the level of
uninduced cells. It is possible that the initial increase in the
ERK1 activity may be required for the initiation but not for
the maintenance of encystation. Also a parallel decrease in the
concentration of phospho-ERK1 and -ERK2 at 24 h suggests
that the activating phosphorylation of ERK1 and ERK2 might
be necessary for the complete activation of giardial ERK1 and
ERK2 as observed in mammalian ERK1/2.
The results obtained from this study also suggest that the
high bile concentration in the encystation medium, which may
induce cholesterol starvation, may be a factor that indirectly
prevents ERK1 and ERK2 activation. However, it is interesting
that the exposure to a high bile concentration and thereby low
FIG. 8. In vitro kinase assay with immunoprecipitated gERK1.
Trophozoites were allowed to encyst for the times indicated, and gERK1
was immunoprecipitated from the crude cell extracts. Immunoprecipi-
tated ERK1 was used for in vitro kinase assays. A, immunoblot analysis
of the ERK1 in the crude extract prior to immunoprecipitation showing
the level of ERK1 expression. B, autoradiogram showing phosphoryla-
tion of MBP by the immunoprecipitated extracts. C, Coomassie Blue-
stained SDS-PAGE of the kinase assay showing equal amounts of added
MBP. D, densitometric analysis of the phosphorylated MBP by the
immunoprecipitated ERK1 at different times of encystation. Data rep-
resent mean  S.D. of three separate experiments.















cholesterol concentration generated signals that may have dif-
ferent effects on the activation of ERK1 and ERK2. This finding
also suggests the possibility that the function of giardial ERK1
and ERK2 may be regulated through different mechanisms.
Differential phosphorylation of ERK1 and ERK2 by the PCPH
oncogene has been reported in 293T cells (43). It was proposed
that in these cells, ERK1 activation might have been mediated
through a Ras/MEK-independent pathway (43). Although Gi-
ardia homologues of MEK and MEKK have been identified, it
is not known which signaling pathway(s) activates ERK1 and
ERK2 in trophozoites and in encysting cells. In depth studies
are needed to elucidate the regulation of activation of giardial
ERK1/ERK2 during encystation.
The first step of encystation is the induction of expression of
CWP proteins, which is triggered by the depletion of choles-
terol. It has been shown that in higher eukaryotes, cholesterol
homeostasis is maintained by the transcription activation of
various genes through activation of transcription factors,
SREBP1a and SREBP2, that bind to the sterol-response ele-
ment (SRE) (44). The promoter of CWP1 and CWP2 contains
degenerated SRE, and it has been hypothesized that CWP
expression might be induced by interaction with the SRE-
binding proteins (SREBP) (44). Importantly, recent studies (45)
have shown that mammalian SREBP1a and SREBP2 are acti-
vated by ERK1 and ERK2, and their activation may be linked
to the MAPK cascade. It is possible that the activation of CWP
gene transcription during encystation is mediated through
SREBP, which is in turn activated by ERK1. Recently, the
observation that Giardia trophozoites express a cell-surface
cholesterol-sensing receptor, receptor-Ck, and SREBP (26),
suggests that a sterol-regulated signaling pathway might be
present in Giardia. So far, no information on the function of
giardial homologues of SREBP is available. Further study in
this area will shed light on the involvement of ERK1 in tran-
scription of CWP genes.
Based on our observations, we speculate that inactivation of
ERK2 was necessary for the formation of cysts, whereas an
increased activity of ERK1 was a prerequisite for the encysta-
tion process to begin. Phosphorylation status of ERK1 and
ERK2 correlated best with the activity profile at 24 h support-
ing the conjecture of inactivation of ERK1 and ERK2 during
encystation. However, despite the fact that the activity of
ERK1 and ERK2 was back to the original level in cells at 48 h
upon maintaining them in TYI-S-33 media for the last 24 h, no
significant change in the localization of ERK1 or ERK2 was
noted in encysting cells except for the lack of accumulation of
ERK1 in the ventral groove. Functional significance of the
FIG. 9. In vitro kinase assay with immunoprecipitated gERK2.
Trophozoites were allowed to encyst for the times indicated, and gERK2
was immunoprecipitated from the crude cell extracts. Immunoprecipi-
tated ERK2 was used for in vitro kinase assays. A, immunoblot analysis
of the ERK2 in the crude extract prior to immunoprecipitation showing
the level of ERK2 expression. B, autoradiogram showing phosphoryla-
tion of MBP by the immunoprecipitated extracts. C, Coomassie Blue-
stained SDS-PAGE of the kinase assay showing equal amounts of added
MBP. D, densitometric analysis of the phosphorylated MBP by the
immunoprecipitated ERK2 at different times of encystation. Data rep-
resent mean  S.D. of three separate experiments.
FIG. 10. Assessment of the concen-
tration of phospho-ERK1/ERK2 dur-
ing encystation. A, detection of the
phospho-ERK1 and -2 and dephosphoryl-
ated ERK1 and -2 in crude trophozoite
extracts (30 g) with and without treat-
ment with  phosphatase to determine
the specificity of the phospho-ERK anti-
body. B, Western blot analysis of the re-
combinant ERK1 and -2 using anti-phos-
pho-ERK and anti-gERK1 and-gERK2
antibodies to confirm that phospho-ERK
antibody does not recognize dephospho-
rylated ERK1 and 2. C, immunoblot anal-
ysis of the dephosphorylated ERK1 and
ERK2 using anti-ERK1 (1:4,000) and
ERK2 (1:30,000) antibodies together
(panel a) and phosphorylated ERK1 and
ERK2 using an anti-phospho ERK anti-
body (1:100) (panel b) in the crude ex-
tracts (50 g) from encysting cells at dif-
ferent stages of encystation. Expression of
CWP1 protein (panel c) using anti-CWP1
antibody (1:1  106) was used as a marker
for encystation.















differential distribution and activity of ERK1 and ERK2 during
encystation remains to be determined.
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